Scientific Letter N°5

It has now been two years that ATLANCHIM PHARMA has been taken over and we are pleased to notice that thanks to the efforts and trust of all, we carry on with our development, despite a difficult economic environment.
Indeed, after a staff increase and equipment investments in 2009, 2010 is a pivotal year in corporate life with for major change, the laboratory moving. Thus, since 6 April 2010, ATLANCHIM PHARMA joined the team of ATLANTIC BONE SCREEN (parent company), by integrating the site of the Faculty of Medicine and Pharmacy of Nantes.
We thus benefit today from a doubled surface (500 m² in total among which 200 m² for ATLANCHIM PHARMA) and easier access to laboratory equipment. In addition, the gathering of the two companies enhances interactivity between them, thereby providing complementary personalized services (medicinal chemistry and biological validation of the synthesized
molecules).
In this new edition of our scientific newsletter, we will present the portrait of our Legal and Human Resources Manager, our Head of Production (Doctor in Chemistry) and the portrait of an Assistant Project Manager (Engineer in biology). You will also be pleased to discover the scientific paper entitled « Cu-Catalyzed Azide-Alkyne Cycloaddition: “The Click Reaction” », written by one of our Scientific Directors, Prof. Jacques LEBRETON.
ATLANCHIM PHARMA team joins me in wishing you a nice reading of our Scientific Letter.

Ronan LE BOT
Directeur